53
Views
10
CrossRef citations to date
0
Altmetric
Orginal Articles

Occupational exposure of pharmaceutical workers to drug actives and excipients and their effect on Staphylococcus spp. nasal carriage and antibiotic resistance

, , &
Pages 207-214 | Published online: 03 Dec 2013

References

  • Kern DG, Kern E, Crausman RS, Clapp RW. A retrospective cohort study of lung cancer incidence in nylon flock workers, 1998–2008. Int J Occup Environ Health. 2011;17(3):345–51.
  • Dimich-Ward H, Le Nhu D, Beking K, Dybuncio A, Spinelli JJ, Gallagher RP, et al. Congenital anomalies in the offspring of nurses: association with area of employment during pregnancy. Int J Occup Environ Health. 2011;17(3):195–201.
  • Kluytmans J, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505–20.
  • Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR. The human nasal microbiota and Staphylococcus aureus carriage. PLoS ONE [internet] 2010 [cited 2013 Jan 8];5:e10598. Available from: http://www.plosone.org/article/info%3Adoi/10·1371/journal.pone.0010598.
  • Perl TM, Golub JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother. 1998;32(Suppl 1):S7–16.
  • Lai C-F, Liao C-H, Pai M-F, Chu F-Y, Hsu S-P, Chen H-Y, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:167–74.
  • Agarwal JA, Verma RK, Awasthi S, Singh KP. Intravenous device associated blood stream staphylococcal infection in paediatric patients. Indian J Med Res. 2011;134:193–9.
  • File TM. Jr Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting. Cleve Clin J Med. 2007;74(Suppl 4):S6–11.
  • Pacheco RL, Lobo RD, Oliveira MS, Farina EF, Santos CR, Costa SF, et al. Methicillin-resistant Staphylococcus aureus (MRSA) carriage in a dermatology unit. Clinics (Sao Paulo). 2011;12:2071–7.
  • AL-Zub’I E, Bdour S, Shehabi AA. Antibiotic resistance patterns of mec a-positive Staphylococcus aureus isolates from clinical specimens and nasal carriage. Microb Drug Resist. 2004;10:321–4.
  • Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents. 2000;16(Suppl 1):S3–10.
  • Tufariello JM, Lowy FD. Coagulase-negative staphylococci: Antimicrobial resistance and treatment. In: Sexton DJ, Kaplan SL, (eds.) UpToDate. Waltham, MA. 2013 [cited 2013 Jan 8]. Available from: http://www.uptodate.com/contents/coagulase-negative-staphylococci-antimicrobial-resistance-and-treatment.
  • Anonymous. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. Clinical and Laboratory Standards Institute, CLSI document M100-S20. Wayne, PA, USA. 2010;30(1).
  • Anonymous. Identification of Staphylococcus species, Micrococcus species and Rothia species. Standards Unit, Evaluations and Standards Laboratory, BSOP ID7, 2007; Issue 2.1.
  • Magiorakos AP, Srinivasan A-M, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.
  • Ku R. An overview of setting occupational exposure limits (OELs) for pharmaceuticals. Chem Hlth & Safety. [Internet] 2000 [cited 2013 Apr 24]. Available from: http://www.safebridge.com/pdf_docs/overview_of_setting_oel.pdf.
  • Naumanna BD, Weidemana PA. Scientific basis for uncertainty factors used to establish occupational exposure limits for pharmaceutical active ingredients. Hum Ecol Risk Assess. 1995;1(5): 590–613.
  • Sessink PJ, Timmersmans JL, Anzion RB, Bos RP. Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil. J Occup Med. 1994;36(1):79–83.
  • Sessink PJ, Friemel NS, Anzion RB, Bos RP. Biological & environmental monitoring of occupational exposure of pharmaceutical plant workers to methotrexate. Int Arch Occup Environ Health. 1994;65(6):401–3.
  • Heron RJ, Pickering FC. Health effects of exposure to active pharmaceutical ingredients (APIs). Occup Med (Lond). 2003;53(6):357–62.
  • Antunes J, Silva R, Pacheco D, Filipe P. Occupational contact allergy to cephalosporins. Dermatol Online J [Internet] 2011 [cited 2013 Apr 24];17(5):13. Available from: http://dermatology.cdlib.org/1705/6_letters/13_11-00120/article.html.
  • Coutts II, Dally MB, Taylor AJ, Pickering CA, Horsfield N. Asthma in workers manufacturing cephalosporins. Br Med J. 1981;283(6297):950.
  • Khashu M, Osiovich H, Henry D, Al Khotani A, Solimano A, Speert DP. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative staphylococcus in a neonatal intensive care unit. Pediatrics. 2006;117:340–8.
  • Hanselman BA, Kruth SA, Rousseau J, Weese JS. Methicillin-resistant Staphylococcus aureus colonization in schoolteachers in Ontario. Can J Infect Dis Med Microbiol. 2008;19:405–8.
  • Askarian M, Zeinalzadeh A, Japoni A, Alborzi A, Memish ZA. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran. J Infect Dis [Internet] 2009 [cited 2013 Jan 8];13:e241-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19269873.
  • Cremniter J, Slassi A, Quincampoix J-C, Sivadon-Tardy V, Bauer T, Porcher R, et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol. 2010;48:1428–31.
  • Tan TY, Ng SY, Xing W. Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites. J Clin Microbiol. 2006;44:3413–4.
  • Aren TC, Ohman L. Coagulase-negative staphylococci and sternal infections after cardiac operation. Ann Thorac Surg. 2000;69:1104–9.
  • Wallmark G, Arremark I, Telander B. Staphylococcus saprophyticus: a frequent cause of acute urinary tract infection among female outpatients. J Infect Dis. 1978;138:791–7.
  • Daghistani HI, Issa AA, Shehabi AA. Frequency of nasal and wound isolates of Staphylococcus aureus associated with TSST-1 production in Jordanian population. FEMS Immunol Med Microbiol. 2000;27:95–8.
  • Abed Aljalil H, Jallad M, Thwaini A. Nasal carriage of methicillin resistant Staphylococcus aureus in individuals exposed and not exposed to hospital environments. Eur J Sci Res. 2008;22:570–4.
  • Omuse G, Kariuki S, Revathi G. Unexpected absence of methicillin-resistant Staphylococcus aureus nasal carriage by healthcare workers in a tertiary hospital in Kenya. J Hosp Infect. 2012;80:71–3.
  • Kristiansen JE, Thomsen VF, Martins A, Viveiros M, Amaral L. Non-antibiotics reverse resistance of bacteria to antibiotics. In Vivo. 2010;24(5):751–4.
  • Natoli S, Fontana C, Favaro M, Bergamini A, Testore GP, Minelli S, et al. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC Infectious Diseases [Internet] 2009 [cited 2013 Feb 2];9:83. Available from: http://www.biomedcentral.com/1471-2334/9/83.
  • Melo GB, Bispo PJ, Yu MC, Pignatari AC, Hofling-Lima AL. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye (Lond). 2011;25:382–7.
  • Elsahn AF, Yildiz EH, Jungkind DL, Abdalla YF, Erdurmus M, Cremona FA, et al. In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics. Cornea. 2010;29:1131–5.
  • Falagas ME, Grammatikos AP, Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther. 2008;6:593–600.
  • Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91(Suppl 3B):72S–5S.
  • de Neeling AJ, van Leeuwen WJ, Schouls LM, Schot CS, van Veen-Rutgers A, Beunders AJ, et al. Resistance of staphylococci in the Netherlands: surveillance by an electronic network during 1989–1995. J Antimicrob Chemother. 1998;41:93–101.
  • Chambers HF. Methicillin-resistant staphylococci. Clin Microbiol Rev. 1988;1:173–86.
  • Otto M. Staphylococcus epidermidis – the ‘accidental’ pathogen. Nat Rev Microbiol. 2009;7:555–67.
  • Fredheim EG, Klingenberg C, Rohde H, Frankenberger S, Gaustad P, Flaegstad T, et al. Biofilm Formation by Staphylococcus haemolyticus. Clin Microbiol. 2009;47:1172–80.
  • Bloemendaal AL, Brouwer EC, Fluit AC. Methicillin resistance transfer from Staphylocccus epidermidis to methicillin-susceptible Staphylococcus aureus in a patient during antibiotic therapy. PLoS One [Internet] 2010 [cited 2013 Feb 2];5:e1184. Available from: http://www.plosone.org/article/info%3Adoi%2F10·1371%2Fjournal.pone.0011841.
  • Berglund C, Soderquist B. The origin of a methicillin-resistant Staphylococcus aureus isolate at a neonatal ward in Sweden-possible horizontal transfer of a staphylococcal cassette chromosome mec between methicillin-resistant Staphylococcus haemolyticus and Staphylococcus aureus. Clin Microbiol Infect. 2008;14:1048–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.